Global Resilience System
Caribbean Resilience System
Dominica Information
User is not a member of any group.
There are currently 0 users online.
Updated findings from a nirmatrelvir/ritonavir (Paxlovid) trial in standard-risk COVID-19 suggest the antiviral's benefits are less clear for those not at high risk of severe outcomes.
...
The move could result in the U.N. health agency distributing scarce vaccine doses to rich countries that can otherwise afford them.
Recent Comments